Aisha Jumaan, Mph, PhD
Dr. Jumaan has over 20 years of experience in public health including viral vaccine preventable diseases, cervical and breast cancer research, surveillance, maternal, child health and nutrition, primary health care, and women in development.
Aisha is currently working with as an Independent consultant coordinating health related projects in Yemen. Between 2010 and 2012, Aisha supported the CDC’s Field Epidemiology training Program. Prior to that, she was the director for HPV Vaccines: Evidence for Impact project at PATH. She was with the US Centers for Disease Control and Prevention from 1995 to 2008. She served as team leader for varicella and zoster vaccination program. Previous positions within CDC have been with the National Immunization Program, the Division of Cancer Control and Prevention, the Nutrition Division, and the Agency for Toxic Substances and Disease Registry. She has also held the position of assistant professor at the Rollins School of Public Health, Epidemiology Department at Emory University.
Aisha also worked in her native home, Yemen, with UNFPA and UNDP. She also participated in health-related program development, evaluation, and training activities for Peace Corps. She was an assistant professor on the Faculty of Medicine and Health Sciences, Sana'a University, and consulted on research projects for various ministries, USAID, Save the Children, and Dutch Embassy.
Aisha Jumaan earned her PhD in Epidemiology from the University of North Carolina, Chapel Hill, NC., her Maters in Public Health from Emory University, Atlanta, Ga., and her BA, Biology from Mills College, Oakland, Ca.
Ann Marie Kimball, MD
Ann Marie Kimball is a physician and epidemiologist. A strategic adviser for Rockefeller Foundation, she served as technical and strategic lead for the Bill and Melinda Gates Foundation surveillance strategy formation.
She was also senior program officer with the foundation, prior to which she served as professor of epidemiology at the University of Washington School of Public Health where she is now emerita.
During her tenure at UW, Dr Kimball founded and directed the APEC Emerging Infections Network, and led research and training programs in Peru and Thailand.
Her research focus on global trade and emerging infections earned her a Fulbright New Century Scholars award and a Guggenheim Scholars award.
She is the author of Risky Trade: Infectious Diseases in an Era of Global Trade and has authored numerous scientific publications and served on several Institute of Medicine panels.
Most recently she led the Rockefeller Foundation evaluation of their global disease surveillance network portfolio.
She is a fellow in the American College of Preventive Medicine and member of the National Biosurveillance Advisory group, Centers for Disease Control.
Moh Kilani is an advisor at Galvanize Partners, a consultancy that develops strategic communications solutions for clients, including multinational corporations and international organizations. Kilani has a decade of experience in international business and foreign affairs with a focus on the Middle East and North Africa. He is also a Security Fellow with the Truman National Security Project. Kilani has also worked with communities in the Northwest United States as a civil rights advocate.
Previously, Kilani managed an American export venture in North Africa. He also served as an analyst on leading technologies and developed public-private initiatives that promoted those technologies, including blockchain.
In addition to his work in the Middle East and North Africa, Kilani has both published and presented papers on the Arctic and policy making with a focus on diplomatic initiatives undertaken by city government. He served previously as a fellow at the University of Washington’s Henry M. Jackson School’s International Policy Institute.
Kilani holds a BS in biology from the University of North Carolina at Greensboro and an MA in Applied International Studies from the University of Washington. He is a native speaker of Arabic, with a smattering of Spanish, Mandarin and Cantonese.